Conditions such as pancreatitis, thyroid issues, and kidney problems may affect its suitability
A maintenance microdose of 2.5 mg weekly or even every other week can provide enough appetite suppression to prevent significant regain while minimizing cost and side effects
Given the findings from the LEAD clinical trials, how would you evaluate the trade-offs between liraglutides benefits (e.g., glycemic control, weight loss) and its potential side effects, such as nausea or pancreatitis
Your provider should evaluate potential underlying causes, including thyroid function tests, vitamin B12 levels (especially if you take metformin), complete blood count, comprehensive metabolic panel, A1C, and screening for depression or sleep disorders
Thyroid function, iron levels, and vitamin D status should all be evaluated